Modified-Release Nifedipine: A Review of the Use of Modified-Release Formulations in the Treatment of Hypertension and Angina Pectoris

Author： Croom Katherine F.   Wellington Keri  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.4, 2006-01, pp. : 497-528

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modified-Release Formulation of Trimetazidine for Exceptional Control of Angina Pectoris: Fact or Fiction

By Thadani Udho  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 5, 2005-01 ,pp. : 331-334

Adis International

Access to resources Recommend Favorite

Hydrophilic Polymers for Modified-Release Nanoparticles: A Review of Mathematical Modelling for Pharmacokinetic Analysis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 22, 2015-01 ,pp. : 3090-3096

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Stable Angina Pectoris with Trimetazidine Modified Release in Indian Primary-Care Practice

By Gupta Rajeev  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 5, 2005-01 ,pp. : 325-329

Adis International

Access to resources Recommend Favorite

Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union

By Schug B.S.   Brendel E.   Wolf D.   Wonnemann M.   Wargenau M.   Blume H.H.  

European Journal of Pharmaceutical Sciences, Vol. 15, Iss. 3, 2002-04 ,pp. : 279-285

Elsevier

Access to resources Recommend Favorite

Fabrication and evaluation of captopril modified-release oral formulation

By Gohel Mukesh   Nagori Stavan Arunkumar  

Pharmaceutical Development and Technology, Vol. 14, Iss. 6, 2009-12 ,pp. : 679-686

Informa Healthcare

Access to resources Recommend Favorite